Study: J&J's stent better than Boston Scientific's

09/13/2007 | NYTimes.com

Patients who received Johnson & Johnson's Cypher drug-coated stent were less likely to suffer heart attacks than patients who received Boston Scientific Corp.'s Taxus stent and bare-metal stents, a study revealed. Researchers also found that Taxus stents slightly increased the risk of fatal clots in patients compared with Cypher and bare-metal stents.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations